1. Ye, Qiuwen, Chen, Dong, Liu, Xin, Yu, Tingdong, Tan, Jing. 2024. The EFNA4 gene is a potential prognostic biomarker in pancreatic cancer: a bioinformatics analysis. In Journal of gastrointestinal oncology, 15, 1165-1178. doi:10.21037/jgo-24-227. https://pubmed.ncbi.nlm.nih.gov/38989440/
2. Zhao, Xiangyu, Chen, Yuxing, Sun, Xiaoqin, Diao, Kaixuan, Liu, Xue-Song. 2022. Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis. In Cancers, 14, . doi:10.3390/cancers14174226. https://pubmed.ncbi.nlm.nih.gov/36077763/
3. Ye, Peng, Chen, Zide, Lou, Haibo, Zhu, Xiaolin, Fu, Xihua. 2023. Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation. In Journal of clinical and experimental hepatology, 13, 767-773. doi:10.1016/j.jceh.2023.04.004. https://pubmed.ncbi.nlm.nih.gov/37693261/
4. Zhong, Xingyi, Zhu, Zhiqin, Du, Yangfeng, Lin, Junhao, Chen, Fengsheng. 2024. EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma. In Apoptosis : an international journal on programmed cell death, 30, 349-363. doi:10.1007/s10495-024-02042-4. https://pubmed.ncbi.nlm.nih.gov/39656358/
5. Yuan, Weidong, Zhao, Hewei, Zhou, Ang, Wang, Shaochuang. . Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2. In Cancer biology & therapy, 23, 1-12. doi:10.1080/15384047.2022.2149039. https://pubmed.ncbi.nlm.nih.gov/36404439/
6. Wang, Xian, Zhang, Tiran, Yu, Rong. 2024. EFNA4 deletion suppresses the migration, invasion, stemness, and angiogenesis of gastric cancer cells through the inactivation of Pygo2/Wnt signaling. In Histology and histopathology, 40, 343-356. doi:10.14670/HH-18-779. https://pubmed.ncbi.nlm.nih.gov/38953488/
智鼠故事 
